08.22.25 -- FDA Priority Voucher Program Submissions Window Opens On New Website

Demand for single-use tools, components, expertise, and capabilities continues to grow as innovative cell therapies evolve. However, concerns and misconceptions abound regarding single-use solutions.

To prepare for an FBS shortage, secure reliable suppliers, validate backups, stock reserves, and consider alternative sourcing. Corning offers high-quality FBS and expert supply planning support.

With each batch of cell and gene therapy product representing a wealth of lifesaving potential, this biopharma company needed the right packaging solution for its relatively new therapy applications.

Maximize your research potential by overcoming workflow bottlenecks. Explore flexible strategies for increasing throughput and integrating automation seamlessly into your laboratory operations.

Advancements in gene therapy require robust analytical methods. A roundtable with experts highlights how digital PCR can assess AAV genome integrity for safe and effective therapies.

CAR-T cell therapy has been limited by high costs and lengthy manufacturing. Novel methods are bringing exciting advancements in CRISPR-based gene editing that hold promise for overcoming hurdles.

Experts share their experiences implementing process intensification to provide a holistic perspective and the top considerations for your internal calculations, deliberations, and decision-making.

Bispecific antibodies (bsAbs) are revolutionizing medicine by targeting two disease mechanisms simultaneously. Learn about an innovative platform offering excellent pairing and enhanced productivity.

Discover how one family defied the odds—bringing a lifesaving gene therapy from idea to treatment in just 14 months after a devastating rare disease diagnosis.

To ensure the commercial success of cell therapies, developers must adopt innovative manufacturing and QC technologies that reduce COGS while enhancing scalability, quality, and clinical outcomes.

Find out how a CDMO with extensive experience in protein variant characterization, CQA analytics, and patient-centric product development can ensure the safety and efficacy of your biotherapeutic.

Learn how a systematic approach to scalable plasmid DNA production using E. coli OneShot Top10, which features DOE-driven optimization and key insights for efficient biomanufacturing success.

Discover how this integrated, multi-parameter assay strategy can enhance the accuracy, sensitivity, and efficiency of your ADC potency evaluations.

Ensure precise, validated cleaning processes for your pharmaceutical projects, minimizing downtime and mitigating drug shortages that stem from manufacturing interruptions.

Reduced the risk of contamination caused by repeated handling of the culture during transient protein production in suspension CHO cells.

With tox material in hand as soon as possible, antibody-derived drug developers can conduct their tox studies earlier, facilitating a timely IND submission and speeding up pathways to patients.